How cannabidiol (CBD) interacts with cancer treatments
Official title: Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways
Funded at Research Inst of Fox Chase Can Ctr · NIH-10813799 · Data updated 2026-11-12
This study is looking at how cannabidiol (CBD) might affect the way cancer treatments, like chemotherapy, work for patients, especially those using CBD for pain relief or other benefits during their treatment.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $199,821 |
| NIH project number | 5R21CA280446-02 |
| Project ID | NIH-10813799 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with advanced cancers who are considering or currently using CBD as part of their treatment regimen.
✕Less likely to help
Patients who are not using CBD or are not undergoing systemic cancer therapies may not benefit from this research.
What this research studies
This research investigates the effects of cannabidiol (CBD) on the effectiveness of various cancer therapies, including chemotherapy and targeted treatments. It aims to understand how CBD may influence patient responses to these therapies and the factors that contribute to resistance against treatment. By examining the interaction between CBD and cancer signaling pathways, the study seeks to provide insights that could help tailor cancer treatments to individual patients. Patients using CBD for pain relief or perceived benefits during cancer treatment may find this research particularly relevant.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatment strategies that enhance the effectiveness of therapies for patients using CBD.
How similar studies have gone: While there is growing evidence supporting the interaction of CBD with cancer therapies, this research explores a relatively novel hypothesis that has not been extensively tested.
Where this research is happening
-
Research Inst of Fox Chase Can Ctr
Philadelphia, United States Active
Researchers
- Principal investigator: Golemis, Erica a. — Research Inst of Fox Chase Can Ctr
- Study coordinator: Golemis, Erica a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.